[1]
“Toll-Like Receptors in Innate Immunity: Signalling Pathways and Therapeutic Targets”, IAJLB, vol. 17, no. 2, pp. 9–18, Jun. 2020, doi: 10.62644/iajlb.2020.v17.i2.pp9-18.